No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GNLX Genelux
- 3.520
- -0.280-7.37%
Close Apr 16 16:00 ET
- 3.510
- -0.010-0.28%
Post 17:58 ET
94.57MMarket Cap-3333P/E (TTM)
4.070High3.420Low291.97KVolume3.810Open3.800Pre Close1.04MTurnover1.44%Turnover RatioLossP/E (Static)26.87MShares40.98052wk High4.86P/B71.48MFloat Cap3.42052wk Low--Dividend TTM20.31MShs Float40.980Historical High--Div YieldTTM17.11%Amplitude3.420Historical Low3.557Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Form 144(Amend) | Genelux(GNLX.US) 10% Stockholder Proposes to Sell 2.1 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Genelux(GNLX.US)$ 10% Stockholder SZALAY 2010 RETAINED ANNUITY TRUST intends to sell 494.74K shares of its common stock on Apr 15, with a total market value of approxi
Form 144 | Genelux(GNLX.US) 10% Stockholder Proposes to Sell 2.1 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 11, $Genelux(GNLX.US)$ 10% Stockholder SZALAY 2010 RETAINED ANNUITY TRUST intends to sell 494.74K shares of its common stock on Apr 15, with a total market value of approxi
Genelux Corp Unveils Strategic Corporate Outlook Presentation
After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)
Express News | Benchmark Reiterates Speculative Buy on Genelux, Maintains $30 Price Target
Genelux Is Maintained at Buy by HC Wainwright & Co.
Genelux Is Maintained at Buy by HC Wainwright & Co.
Comments
Cancer Therapy Company Receives Buy Rating From Benchmark
Genelux Corporation: A Speculative Buy Worth Considering?
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
1
$Genelux(GNLX.US$ markets best kept secret right here
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg